How Does 5-ALA Support Antioxidant Defense, Anti-Inflammatory Responses, and Immune Regulation?

5-Aminolevulinic Acid (5-ALA) is a naturally occurring amino acid derivative in living organisms and a key precursor in heme biosynthesis. When combined with Sodium Ferrous Citrate (SFC), 5-ALA may work through the Nrf2-HO-1 pathway to support antioxidant defense, anti-inflammatory responses, and balanced immune regulation.

Research Design

Published in the International Immunopharmacology, this study conducted a systematic investigation using cell-based assays and multiple animal disease models. The findings demonstrated that 5-ALA exhibits two key biological activities. On the one hand, it can selectively accumulate as protoporphyrin IX (PpIX) in tumor cells, supporting tumor fluorescence diagnosis and photodynamic therapy (PDT). On the other hand, 5-ALA can upregulate heme oxygenase-1 (HO-1) expression, promoting the production of bioactive molecules such as carbon monoxide (CO) and biliverdin. This mechanism may help alleviate ischemic organ injury, excessive inflammatory responses, and immune dysregulation, highlighting the promising potential of 5-ALA in areas such as cardiac hypertrophy, renal injury, transplant rejection, and fibrotic diseases.

Research Findings

The study revealed distinct metabolic differences between normal and cancer cells. Due to insufficient ferrochelatase (FECH) activity in tumor cells, exogenous 5-ALA leads to substantial accumulation of protoporphyrin IX (PpIX). Upon exposure to light at a specific wavelength, PpIX produces red fluorescence and generates reactive oxygen species (ROS), enabling tumor detection and photodynamic destruction. In normal cells, Sodium Ferrous Citrate (SFC) facilitates heme biosynthesis, thereby inducing heme oxygenase-1 (HO-1) expression and promoting the production of carbon monoxide (CO) and biliverdin, which contribute to cytoprotection and anti-inflammatory effects.

The combination of 5-ALA and SFC activates HO-1 through two complementary pathways. First, activation of MAPK signaling pathways, including p38 and ERK, promotes the dissociation of Nrf2 from Keap1 and its subsequent translocation into the nucleus. Second, intracellular heme binds to and inactivates the transcriptional repressor Bach1, thereby relieving the suppression of HO-1 gene transcription. Through the synergistic action of these two pathways, HO-1 protein expression is markedly enhanced, making it a key regulatory target for cellular and tissue protection.

The HO-1 metabolites CO and biliverdin can help counteract oxidative stress and protect damaged tissues. Meanwhile, they promote the polarization of macrophages toward the anti-inflammatory M2 phenotype and support the expansion of regulatory dendritic cells and regulatory T cells (Tregs), contributing to immune tolerance. These mechanisms may help suppress excessive inflammatory responses and allograft rejection, while also alleviating tissue fibrosis, highlighting the potential of the 5-ALA/SFC combination in a range of therapeutic applications.
Multiple authoritative experimental studies have demonstrated that the 5-ALA + SFC combination may alleviate hydrogen peroxide–induced cardiomyocyte hypertrophy, reduce renal ischemia-reperfusion injury, and prolong allogeneic heart graft survival. It has also shown potential in improving skin fibrosis associated with scleroderma and cyclosporine-induced nephrotoxicity. Collectively, these findings from multiple animal models provide evidence supporting the potential of the 5-ALA/SFC combination for anti-inflammatory and organ-protective effects, as well as immune regulation.
 

Research Summary

Multiple experimental studies have demonstrated that 5-Aminolevulinic Acid (5-ALA) exhibits diverse biological activities, including its potential as a photodynamic therapy (PDT) agent for tumor applications, antioxidant and liver/kidney protective effects, anti-inflammatory activity, and immune homeostasis regulation. These properties highlight its potential for use across multiple fields, including pharmaceutical intermediates, functional food ingredients, and active cosmetic formulations.

Hanhe Bio utilizes synthetic biotechnology to achieve the green, scalable production of high-purity 5-ALA raw materials. With product specifications aligned with those used in published research, the material offers stable purity and controllable large-scale production, providing standardized raw material solutions for the pharmaceutical, health food, and beauty industries.

（This content is intended for academic and industry communication only and does not constitute medical or health advice. Please consult a qualified healthcare professional for health-related concerns.）
 

References
Masayuki Fujino,Yoshiaki Nishio,Hidenori Ito, Tohru Tanaka,Xiao-Kang Li.5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction[J].International Immunopharmacology,2015.